July 23, 2012 — A recent study published in the American Journal of Roentgenology has reconfirmed that virtual colonoscopy (CT colonography) is an effective screening tool for colorectal cancer in seniors age 65 and older.

July 23, 2012 — The U.S. Food and Drug Administration (FDA) granted Ferring Pharmaceuticals Inc. approval to market Prepopik (sodium picosulfate, magnesium oxide and anhydrous citric acid) for oral solution indicated for cleansing of the colon as a preparation for colonoscopy in adults. Prepopik is a low-volume, orange-flavored, dual acting, stimulant and osmotic laxative.

July 23, 2012 — Accuray Inc. announced it has signed a definitive agreement to acquire Morphormics Inc., a privately held company founded by University of North Carolina at Chapel Hill faculty members based on their research in autosegmentation of medical images.

July 23, 2012 — The IT and medical technology company Sectra has acquired the product rights for Intulo, a system that monitors radiation doses, from the Swedish medical IT company Krucom AB. The system enables major time and quality gains in medical care and reduces the risk of patients being exposed to unnecessarily high radiation doses in conjunction with radiology examinations.

 

July 23, 2012 — Viatronix Incorp. announced that the stage finally appears set for a reversal of the May 2009 non-coverage decision for screening CT Colongraphy (CTC) by The Centers for Medicare and Medicaid Services (CMS). The latest CTC study, "CT Colonography of a Medicare-Aged Population: Outcomes Observed in an Analysis of More Than 1,400 Patients" (American Journal of Roentgenology, AJR2012; 199:W27-W34), provides good evidence that CT Colonography is an effective screening tool for colorectal cancer in the Medicare-aged population. The lack of Medicare-age specific data on CTC was the primary reason given for CMS' non-coverage decision.

July 23, 2012 — Siemens Healthcare expands its ultrasound portfolio with the portable Acuson P300 ultrasound system designed for a wide variety of clinical settings. Integrating high-performance hardware and software, the Acuson P300 system offers 13 multifrequency transducers for high clinical versatility. The system also features advanced image optimization technologies to support both routine and specialty application needs.

Acuson P300 Ultrasound System

July 20, 2012 —Acusphere Inc. announced that it had completed the marketing authorization application (MAA) dossier for its lead product candidate, Imagify (perflubutane polymer microspheres) for injectable suspension, and is now starting the process of filing the MAA dossier with the European Medicines Agency (EMA) to support the regulatory review of Imagify in the European Union.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now